中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

儿童药物性肝损伤的用药分析及临床特征

张艳芳 郭玉明 牛明 葛斐林 景婧 朱云 朱世殊 韩紫欣 王伽伯 刘士敬 肖小河

张艳芳, 郭玉明, 牛明, 葛斐林, 景婧, 朱云, 朱世殊, 韩紫欣, 王伽伯, 刘士敬, 肖小河. 儿童药物性肝损伤的用药分析及临床特征[J]. 临床肝胆病杂志, 2019, 35(3): 579-584. DOI: 10.3969/j.issn.1001-5256.2019.03.025.
引用本文: 张艳芳, 郭玉明, 牛明, 葛斐林, 景婧, 朱云, 朱世殊, 韩紫欣, 王伽伯, 刘士敬, 肖小河. 儿童药物性肝损伤的用药分析及临床特征[J]. 临床肝胆病杂志, 2019, 35(3): 579-584. DOI: 10.3969/j.issn.1001-5256.2019.03.025.
Zhang YanFang, Guo YuMing, Niu Ming, Ge FeiLin, Jing Jing, Zhu Yun, Zhu ShiShu, Han ZiXin, Wang JiaBo, Liu ShiJing, Xiao XiaoHe. Drug-induced liver injury in children:An analysis of medication and clinical features[J]. J Clin Hepatol, 2019, 35(3): 579-584. DOI: 10.3969/j.issn.1001-5256.2019.03.025.
Citation: Zhang YanFang, Guo YuMing, Niu Ming, Ge FeiLin, Jing Jing, Zhu Yun, Zhu ShiShu, Han ZiXin, Wang JiaBo, Liu ShiJing, Xiao XiaoHe. Drug-induced liver injury in children:An analysis of medication and clinical features[J]. J Clin Hepatol, 2019, 35(3): 579-584. DOI: 10.3969/j.issn.1001-5256.2019.03.025.

儿童药物性肝损伤的用药分析及临床特征

DOI: 10.3969/j.issn.1001-5256.2019.03.025
基金项目: 

基于临床病证的传统无毒中药肝毒性客观辨识及机制研究(81630100); 国家中医药管理局中医药行业科研专项(201507004-4-2); 国家“重大新药创制”科技重大专项(2015ZX09501-004-001-008); 

详细信息
  • 中图分类号: R725.7

Drug-induced liver injury in children:An analysis of medication and clinical features

Research funding: 

 

  • 摘要:

    目的探讨导致儿童药物性肝损伤(DILI)的损肝药物及其发生的相关危险因素,为儿童临床安全用药提供参考。方法对解放军总医院第五医学中心2008年1月-2017年12月187例0~14岁儿童DILI的用药史、生化指标、症状体征及临床转归等进行回顾性分析。采用整合证据链法将其中127例可获取用药信息的DILI病例分为西药致DILI组(西药组,n=75)、中药致DILI组(中药组,n=15)及中西药联用致DILI组(中西药联用组,n=37)。比较不同组间的用药原因、用药时间和潜伏期、药物分类的差异。偏态分布的计量资料多组间比较采用Kruskal-Wallis H检验,进一步两两比较采用Nemenyi检验,计数资料组间比较采用χ2检验。结果重度及重度以上肝损伤的儿童DILI有116例,占全部病例的62%(116/187),其中肝移植3例,死亡1例,45例(24%)发生慢性化。西药组和中西药联用组的可疑损肝西药均以抗菌药和解热镇痛抗炎药为主,分别占各组的42%和30%、56%和31%。中药组的可疑损肝药物以治疗皮肤病的中药为主,占中药组的47%,且主要为何首乌制剂(33%)。3组间用药时间(H=1...

     

  • [1] Drug-induced Liver Disease Study Group, Chinese Society ofHepatology, Chinese Medical Association. Guidelines for themanagement of drug-induced liver injury[J]. J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
    [2] GAN Y, DONG Y, ZHANG HF, et al. Clinical characteristicsand outcomes of drug-induced liver injury in children:Astudy of 184 cases[J]. J Clin Hepatol, 2015, 31 (8) :1244-1247. (in Chinese) 甘雨, 董漪, 张鸿飞, 等. 184例儿童药物性肝损伤的临床特征及转归状况评价[J].临床肝胆病杂志, 2015, 31 (8) :1244-1247.
    [3] AMIN MD, HARPAVAT S, LEUNG DH, et al. Drug-inducedliver injury in children[J]. Curr Opin Pediatr, 2015, 27 (5) :625-633.
    [4] FAA G, EKSTROM J, CASTAGNOLA M, et al. A developmen-tal approach to drug-induced liver injury in newborns andchildren[J]. Curr Med Chem, 2012, 19 (27) :4581-4594.
    [5] ZHANG CP, MA Y. Analysis of 29 cases with drug-induced liverinjury in children[J]. J Pediatr Pharm, 2015, 21 (1) :44-47. (inChinese) 张长平, 马燕. 29例儿童药物性肝损伤临床分析[J].儿科药学杂志, 2015, 21 (1) :44-47.
    [6] DU SX, LU LL, MIAO YX, et al. Features of children with drug-induced liver injury:An analysis of 34 cases[J]. J PracHepatol, 2016, 19 (5) :607-609. (in Chinese) 杜水仙, 卢琳琳, 苗英霞, 等.儿童药物性肝损伤34例分析[J].实用肝脏病杂志, 2016, 19 (5) :607-609.
    [7] ZHU XX, WAN CM. Recent progress in management and treat-ment of drug-induced liver injury in children[J]. J Clin Hepa-tol, 2012, 28 (12) :896-898. (in Chinese) 朱欣欣, 万朝敏.儿童药物性肝损害[J].临床肝胆病杂志, 2012, 28 (12) :896-898.
    [8] Branch of Hepatobiliary Diseases, China Association of Chi-nese Medicine, Branch of Chinese Patent Medicine, China As-sociation of Chinese Medicine. Guidelines for the clinical man-agement of herb-induced liver injury[J]. J Clin Hepatol, 2016, 32 (5) :835-843. (in Chinese) 中华中医药学会肝胆病分会, 中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].临床肝胆病杂志, 2016, 32 (5) :835-843.
    [9] WANG JB, MA ZJ, NIU M, et al. Evidence chain-basedcausality identification in herb-induced liver injury:Exemplifi-cation of a well-known liver-restorative herb Polygonum mul-tiflorum[J]. Front Med, 2015, 9 (4) :457-467.
    [10] HE TT, ZHONG XW, ZHANG N, et al. Prospective clinicalstudy of 187 cases with liver damage caused by medicine andits preparations[J]. Chin Hepatol, 2018, 23 (8) :666-669. (in Chinese) 何婷婷, 钟学文, 张宁, 等. 187例中草药及其制剂导致肝损伤病例前瞻性临床研究[J].肝脏, 2018, 23 (8) :666-669.
    [11] ZHU Y, LI YG, WANG JB, et al. Causes, features, and out-comes of drug-induced liver injury in 69 children from China[J]. Gut Liver, 2015, 9 (4) :525-533.
    [12] CHALASANI N, FONTANA RJ, BONKOVSKY HL, et al. Cau-ses, clinical features, and out-comes from a prospectivestudy of drug-induced liver injury in the united states[J].Gastroenterology, 2008, 135 (6) :1924-1934.
    [13] REN ZQ, WANG JH, GUO XY, et al. A review analysis of chi-nese literatures 2005-2014:Clinical features of drug-in-duced liver injury[J]. Chin J Pharmacoepidemiol, 2016, 25 (5) :284-289. (in Chinese) 任张青, 王进海, 郭晓燕, 等. 2005~2014年我国药物性肝损伤临床综合分析[J].药物流行病学杂志, 2016, 25 (5) :284-289.
    [14] QI YB, QIU L, JIANG HL, et al. Clinical characteristics ofdrug-induced liver injury:An analysis of 394 cases[J]. JClin Hepatol, 2014, 30 (5) :438-441. (in Chinese) 祁亚宾, 邱玲, 姜红丽, 等.药物性肝损伤394例临床特点分析[J].临床肝胆病杂志, 2014, 30 (5) :438-441.
    [15] YUAN L, YANG YG, SHEN YX, et al. Research advances indrug-induced liver injury[J]. J Clin Hepatol, 2017, 33 (2) :375-378. (in Chinese) 袁玲, 杨永耿, 沈有秀, 等.药物性肝损伤的研究进展[J].临床肝胆病杂志, 2017, 33 (2) :375-378.
    [16] WANG L. Analysis of the disease composition and householdregistration of hospitalized children in Beijing[J]. Chin MedRecord, 2018, 19 (6) :35-37. (in Chinese) 王丽.北京市住院儿童疾病构成与户籍分析[J].中国病案, 2018, 19 (6) :35-37.
    [17] SQUIRES RH Jr, SHNEIDER BL, BUCUVALAS J, et al. Acuteliver failure in children:The first 348 patients in the pediatric a-cute liver failure study group[J]. J Pediatr, 2006, 148 (5) :652-658.
    [18] MURRAY KF, HADZIC N, WIRTH S, et al. Drug-related hep-atotoxicity and acute liver failure[J]. J Pediatr GastroenterolNutr, 2008, 47 (4) :395-405.
    [19] ZHU Y, LIU SH, WANG JB, et al. Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and itspreparations[J]. Chin J Integr Tradl Western Med, 2015, 35 (12) :1442-1447. (in Chinese) 朱云, 刘树红, 王伽伯, 等.何首乌及其制剂导致药物性肝损伤的临床分析[J].中国中西医结合杂志, 2015, 35 (12) :1442-1447.
    [20] HE TT, GONG M, BAI YF, et al. Clinical analysis of two diag-nosis methods for herb-induced liver injury[J]. China J ChinMater Med, 2016, 41 (16) :3096-3099. (in Chinese) 何婷婷, 宫嫚, 白云峰, 等. 2种药物性肝损伤诊断指南的应用分析[J].中国中药杂志, 2016, 41 (16) :3096-3099.
  • 期刊类型引用(11)

    1. 陈思琪,谢琴琴,王红力,钟贵遵,季欢欢,简畅,贾运涛. 儿童药物性肝损伤研究趋势及热点的文献计量学分析. 中国药业. 2024(03): 50-57 . 百度学术
    2. 张胜男,白朝辉,刘蕾,许耀. 62例儿童药物性肝损伤的回顾性分析. 肝脏. 2023(01): 105-107+134 . 百度学术
    3. 唐姗姗,吴然. 中药治疗浅部真菌病研究进展. 中国真菌学杂志. 2023(02): 172-177 . 百度学术
    4. 成小红. 皮肤病外用中药制剂的发展和展望. 中国处方药. 2022(05): 159-161 . 百度学术
    5. 朱世殊,董漪. 儿童药物性肝损伤的诊断与鉴别诊断. 中国实用儿科杂志. 2022(07): 496-500 . 百度学术
    6. 张全超,蔡陈超,刘江龙,沈煜楠,阳丽梅. 福建省近十年药物性肝损伤不良反应特征分析. 海峡药学. 2022(12): 155-160 . 百度学术
    7. 王丽旻,闫建国,甘雨,张鸿飞,朱世殊. 儿童不同临床分型药物性肝损害并发症及预后分析. 中国肝脏病杂志(电子版). 2022(04): 62-67 . 百度学术
    8. 周力. 中西药所致药物性肝损伤临床及病理特点研究. 临床医药文献电子杂志. 2020(39): 56 . 百度学术
    9. 郜丹,刘亚蕾,景婧,朱敬肖,牛明,王伽伯,肖小河,李林,郭玉明,张兰. 骨病用药相关肝损伤不良反应流行趋势分析. 中国中药杂志. 2020(16): 3974-3980 . 百度学术
    10. 刘登宇,吴建美,曲琳. 中药合剂对皮肤浅部真菌病致病菌作用的现况. 医学动物防制. 2020(12): 1161-1163 . 百度学术
    11. 王红玉,吴捷. 146例儿童肝功能异常的病因分析. 临床肝胆病杂志. 2020(11): 2521-2523 . 本站查看

    其他类型引用(5)

  • 加载中
计量
  • 文章访问数:  1684
  • HTML全文浏览量:  54
  • PDF下载量:  351
  • 被引次数: 16
出版历程
  • 出版日期:  2019-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回